Cagrilintide 10 mg vial
- Peptide Plugs$60Listed priceCOA tested Oct 15, 2026
- Blue Ridge Peptides$65Listed priceCOA tested May 16, 2026
- RUO$84Listed price · deal not verifiedCOA tested May 6, 2026
Cagrilintide is a long-acting amylin analog in clinical development for weight-management and metabolic indications, including combinations with semaglutide.
Also known as amylin analog · cag · cagri · cagrilinitide · cagrilintide · cagrlintide
Current picks · Nov 14, 2026
Up to three of the lowest effective prices per exact product among vendors that passed the trust floor, were in stock and checked within 72 hours, and have a COA on file for that product and strength tested within 12 months. Affiliate relationships never affect picks or their order.
Same format. Same amount.
2 of 2 exact products have at least one pick. Vendor counts reflect the current price observations. Testing records for every vendor and strength: Cagrilintide COAs →
Historical market context
Historical market low and median per mg across recorded offers. These market summaries are separate from our exact-product comparisons.
History updated Sep 21, 2026. Vendor coverage, package sizes, product forms and promotions can vary over time. Use exact-product comparisons for current listed prices; historical market prices do not establish vendor trust.
| Date | Low /mg | Median /mg | Vendors | Offers |
|---|---|---|---|---|
| $1.80 | $8.50 | 57 | 89 | |
| $2.00 | $9.04 | 54 | 83 | |
| $3.92 | $10.62 | 35 | 59 | |
| $1.08 | $9.60 | 22 | 46 |
What it is
PubChem links cagrilintide to registered clinical research. It acts through amylin-related pathways and is different from GLP-1 receptor agonists even when the compounds are studied together.
This label describes the available research record, not whether the compound is safe or effective for an individual.
Research context
The bounded search found multiple human trial records involving body weight, glucose regulation, and combination therapy. Development-stage results and combination studies should not be converted into claims about unapproved research products.
Search indexed research for this compound ↗Market context
Cagrilintide is commonly sold or discussed for appetite, weight management, glucose control, and metabolic research. That describes market demand, not proof that the compound is safe or effective.
Market demand and online discussion do not establish product quality, safety, or effectiveness.Vendor directory
Grades describe the vendor record overall, not a test of every product. Lowest prices are effective single-package prices across formats; open a comparison for the exact product.
| Vendor | Grade | Offers | In stock | Lowest effective package |
|---|---|---|---|---|
| Amino Science | Grade A- | 1 | 1 | $141.99 · 10 mg vialObserved Nov 14, 2026 |
| EZ Peptides | Grade A- | 2 | 2 | $44 · 5 mg vialObserved Nov 14, 2026 |
| Peptide Plugs | Grade A- | 1 | 1 | $60 · 10 mg vialObserved Nov 14, 2026 |
| Polaris Peptides | Grade A- | 2 | 2 | $80 · 5 mg vialObserved Nov 14, 2026 |
| Forge Performance Co | Grade A- | 1 | 1 | $70 · 10 mg vialEarlier observation Sep 27, 2026 |
| Evolve Peptides | Grade A- | 2 | 2 | $85.90 · 5 mg vialObserved Nov 14, 2026 |
| GenPeptide | Grade A- | 1 | 1 | $40 · 5 mg vialEarlier observation Oct 20, 2026 |
| Orbitrex Peptides | Grade A- | 1 | 1 | $89.99 · 10 mg vialObserved Nov 14, 2026 |
| Bulk Peptide Supply | Grade B+ | 1 | 1 | $30 · 10 mg vialObserved Nov 14, 2026 |
| Ameano Peptides | Grade B+ | 2 | 2 | $49 · 5 mg vialObserved Nov 14, 2026 |
| Blue Ridge Peptides | Grade B+ | 1 | 1 | $65 · 10 mg vialObserved Nov 14, 2026 |
| Alpha Peps | Grade B+ | 2 | 2 | $70 · 5 mg vialObserved Nov 14, 2026 |
| Alpha Pro Peptides | Grade B+ | 2 | 2 | $35 · 5 mg vialObserved Nov 14, 2026 |
| Peptide Crafters | Grade B+ | 1 | 1 | $95 · 10 mg vialEarlier observation Nov 1, 2026 |
| Prime Lab Peptides | Grade B+ | 1 | 1 | $150 · 10 mg vialEarlier observation Oct 28, 2026 |
| Oasis Peptides | Grade B+ | 1 | 1 | $81 · 5 mg vialObserved Nov 14, 2026 |
| RIVN Peptides | Grade B+ | 1 | 1 | $99.99 · 10 mg vialObserved Nov 14, 2026 |
| Biolongevity Labs | Grade B | 1 | 1 | $170 · 5 mg vialObserved Nov 14, 2026 |
| Coffee and Peppers | Grade B | 2 | 1 | $69.99 · 5 mg vialEarlier observation Oct 4, 2026 · out of stock |
| Paramount Peptides | Grade B | 1 | 1 | $157.25 · 10 mg vialObserved Nov 14, 2026 |
| RUO | Grade B | 1 | 1 | $84 · 10 mg vialObserved Nov 14, 2026 |
| NuLife Peptides | Grade B | 1 | 1 | $80 · 10 mg vialEarlier observation Oct 17, 2026 |
| Amino Amigos | Grade B+ | 1 | 1 | $59.99 · 5 mg vialEarlier observation Nov 13, 2026 |
| AIO Peptides | Not graded | 1 | 1 | $104.80 · 10 mg vialObserved Nov 14, 2026 |
| Nova Life Peptides | Not graded | 1 | 1 | $60 · 5 mg vialObserved Nov 14, 2026 |
| Nuscience Peptides | Not graded | 1 | 1 | $121.99 · 5 mg vialObserved Nov 14, 2026 |
| Peptides 4 Research | Not graded | 1 | 1 | $80 · 5 mg vialObserved Nov 14, 2026 |
| Pura Peptides | Not graded | 1 | 1 | $89.99 · 10 mg vialObserved Nov 14, 2026 |
23 tracked vendors list Cagrilintide without a current offer: Puratek Peptides (Grade A-), Southern Aminos (Grade A-), Rocky Mountain Compounds (Grade B+), Glacier Aminos (Grade B+), Panda Peptides (Grade B+), Peptide Partners (Grade B+), Licensed Peptides (Grade B+), SaiyanMed (Grade B+), Simple Peptide (Grade B), TCore Biotech (Grade B), Ion Peptides (Grade B), Premier Bio Labs (Grade A-), Nationwide Peptides (Grade B+), NextGen Peptides (Grade B), Royal Peptides (Grade B), Vital Core Research (Grade B), Mile High Compounds (Grade B), Oath Research (Grade C), Longevity Peptides (Not graded), Northline Labs (Not graded), Planet Peptide (Not graded), Skye Peptides (Not graded), Tydes (Not graded).
Sources and review
Last editorial review: Aug 30, 2026. Sources support the compound guide only and do not affect vendor grades.